Could stem cells restore erectile function after prostate surgery?

NCT ID NCT07048314

Recruiting now Disease control Sponsor: The Methodist Hospital Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests whether stem cells from donated fat tissue can help men recover erectile function after surgery for localized prostate cancer. Forty men aged 40 to 70 will receive either stem cells or a placebo during or after their prostate removal. The goal is to see if the treatment is safe and improves erections and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs)
What this could lead to: If it works, this could offer a new way to help men recover erectile function after prostate cancer surgery, potentially improving quality of life.
What could go wrong: This is a very early phase 1/2 trial with only 40 people, so results may not apply to everyone. Stem cell treatments can cause side effects like inflammation or serious adverse events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ERECTILE DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

erectile dysfunction prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ERECTILE DYSFUNCTION PROSTATE CANCER

Contacts and locations

Locations

Houston Methodist
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.